Shorter Course of Ledipasvir-Sofosbuvir Therapy Effective in Patients with Genotype 1 Hepatitis C
May 25th 2016Results from the ION-3 trial showed that the rapidity and durability of viral suppression achieved with ledipasvir-sofosbuvir therapy allows a shorter treatment course of 8 weeks in genotype 1, treatment-naïve, non-cirrhotic patients.
Allison Schulman: Implementing New Techniques in Gastric Bypass
May 24th 2016As with all surgical procedures, there are risks that come with gastric bypass surgery. While the procedure itself is not new, there is work being done to make it more effective and longer lasting for patients who utilize this valuable weight loss option.
Five Categories of Lower Gastrointestinal Functional Bowel Disorders in Revised Rome IV Criteria
May 24th 2016The new Rome IV criteria classify the functional bowel disorders into five distinct categories, including irritable bowel syndrome (IBS), functional constipation, functional diarrhea, functional abdominal bloating/distention, and unspecified functional bowel disorder. A new category for opioid-induced constipation, which is distinct from the functional bowel disorders, has been added.